Access cutting-edge hemophilia treatment through this clinical trial at a research site in New Hyde Park. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this New Hyde Park location
Access hemophilia specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hemophilia treatment provided free
Check if you qualify for this hemophilia clinical trial in New Hyde Park, NY
No-Cost Study Care
Local to New Hyde Park
Convenient for NY residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Study B7841007 is an open-label extension study to assess the long-term safety, tolerability, and efficacy of prophylaxis treatment with marstacimab in participants who did not require "Early Termination" from the Phase 3 Study B7841005 and from the Phase 3 Study B7841008. Study B7841005: approximately 145 adolescent and adult participants 12 to \<75 years of age with severe hemophilia A or moderately severe to severe hemophilia B (defined as FVIII activity \<1% or FIX activity ≤2%, respectivel
Sponsor: Pfizer
Yes, this clinical trial (NCT05145127) has an active research site in New Hyde Park, NY that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for hemophilia treatment options in New Hyde Park, NY, this clinical trial (NCT05145127) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New Hyde Park research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hemophilia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all hemophilia clinical trials near you to find additional studies recruiting in your area.
See all pulmonary hypertension clinical trials recruiting in New Hyde Park — not just this study.
Browse Pulmonary Hypertension Trials in New Hyde Park →